[Topical treatment of thrombophlebitis with feprazone and benzydamine. Controlled clinical study].
Topical anti-inflammatory management of superficial and deep phlebopathy with feprazone and benzidamine was compared in a double-blind test. Both drugs were active and well tolerated. Significantly less time was needed to obtain a cure with feprazone.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001591:Benzydamine / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D011298:Feprazone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010146:Pain / Q000188:drug therapy; D010653:Phenylbutazone / Q000031:analogs & derivatives*; D011720:Pyrazoles / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D013924:Thrombophlebitis / Q000188:drug therapy*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D009824:Ointments; D011720:Pyrazoles; D001591:Benzydamine; D011298:Feprazone; D010653:Phenylbutazone
Trattamento topico delle tromboflebiti con feprazone e benzidamina. Studio clinico controllato